Vitamin K News and Research

Latest Vitamin K News and Research

Mach One completes “Definitive Agreement” for merger and acquisition of White Hat Brands

Mach One Corporation, a global wellness solutions company, today announced the completion of a “Definitive Agreement” for the terms and conditions for the merger and acquisition of White Hat Brands, LLC, producers of a variety of all natural, multi-vitamin-fortified juice beverages for children under the brand name Dog On It!™.

23 Mar 2010

You and your baby may need vitamin D supplementation says research

This report appeared in the respected Journal Pediatrics this week. There has been growing awareness regarding deficiency of Vitamin D in children and adults. This vitamin is important for healthy bones, immunity and other bodily processes. In children inadequacy of this vitamin in diet may lead to bone damage, rickets, repeated infections and heart disease in later life.

23 Mar 2010

Ultraviolet portion of sunlight may play bigger role in controlling MS: Study

For more than 30 years, scientists have known that multiple sclerosis (MS) is much more common in higher latitudes than in the tropics. Because sunlight is more abundant near the equator, many researchers have wondered if the high levels of vitamin D engendered by sunlight could explain this unusual pattern of prevalence.

23 Mar 2010

Understanding the African mindset may help promote health education in rural areas

Seen through western eyes, beliefs in supernatural forces are common in Ghana and other African countries. Death, suffering and diseases are often attributed to witchcraft. Over thirty per cent of its inhabitants believe such evil forces could be responsible for the spread of HIV/AIDS.

22 Mar 2010

H1N1 flu pandemic awareness helps Americans to be better prepared this year: Survey

With almost half of respondents saying they believe a sneeze travels eight feet or more, one might think you would be sick all the time. But a recent national survey of 1,017 U.S. adult men and women (age 18+) conducted by Matrixx Initiatives, Inc., maker of Zicam, found a majority of Americans polled surprisingly saw this cold and flu season as "about the same" (42%) or only "slightly worse" (21%) from last year, despite all the hype this past fall around H1N1.

19 Mar 2010

Researchers find retinoic acid regulates SHF tissue formation

Researchers at the Keck School of Medicine of the University of Southern California have identified a key cellular mechanism that guides embryonic heart tissue formation-a process which, if disrupted, can lead to a number of common congenital heart defects.

18 Mar 2010

Low vitamin D levels in African American children connected with high asthma rates

Researchers at Children's National Medical Center have discovered that African American children with asthma in metropolitan Washington, DC, are significantly more likely to have low levels of vitamin D than healthy African American children.

18 Mar 2010

Beneficial impact of vitamin D could alleviate symptoms and treat MS

Glasgow GP Dr Tom Gilhooly is at the forefront of an exciting new treatment for sufferers of MS. He comments ‘Scotland has the greatest incidence of Multiple Sclerosis in the world – and has more to gain than any other country from new developments such as CCSVI.’

18 Mar 2010

Low-impact, weight-bearing exercise does not affect bone density during weight loss

While there are many benefits of losing weight, weight reduction also might negatively affect bones in the body. During weight loss, bones are being remodeled - breaking down old bone and forming new bone - at an accelerated rate.

17 Mar 2010

Vitamin D supplements might do more harm than good for African-American patients

Vitamin D is quickly becoming the "go-to" remedy for treating a wide range of illnesses, from osteoporosis to atherosclerosis. However, new evidence from a Wake Forest University School of Medicine study suggests that supplementing vitamin D in those with low levels may have different effects based on patient race and, in black individuals, the supplement could actually do harm.

16 Mar 2010

RE-LY study: Dabigatran etexilate shows greater reductions in stroke compared to warfarin

Data presented today at the 59th Annual Scientific Session of the American College of Cardiology have shown greater reductions in stroke in patients with atrial fibrillation (AF) for dabigatran etexilate compared to the current standard of care, warfarin, irrespective of a patient’s risk profile for stroke.

16 Mar 2010

Tips for reducing LDL cholesterol

Cardiovascular disease is the No.1 killer in North America. And high cholesterol is one of the primary risk factors of coronary heart disease and stroke. According to the Heart and Stroke Foundation, almost 40% of Canadian adults are classified as having high blood cholesterol levels.

16 Mar 2010

EXPLORE-Xa study: Betrixaban reduces CRNM bleeds compared to dose-adjusted warfarin

Portola Pharmaceuticals and Merck today announced the results of EXPLORE-Xa, a Phase 2 exploratory, dose finding study of betrixaban, an investigational oral direct Factor Xa inhibitor. Results showed that a once-daily dose of oral betrixaban, given to patients with non-valvular atrial fibrillation or atrial flutter and at least one risk factor for stroke, reduced the incidence of major and clinically relevant non-major (CRNM) bleeds compared to dose-adjusted warfarin.

16 Mar 2010

Supplementing vitamin D in people with low levels may have different effects based on patient race

15 Mar 2010

ARS study underlines the importance of vitamin D and its ability to help body utilize calcium

Increasing calcium intake is a common--yet not always successful--strategy for reducing bone fractures. But a study supported in part by the Agricultural Research Service (ARS) underscores the importance of vitamin D and its ability to help the body utilize calcium. The study also may explain why increasing calcium alone isn't always successful in dealing with this problem.

12 Mar 2010

$Bisphosphonate treatments may affect bone quality and increase risk of atypical fractures of femur$

Bisphosphonate treatments may affect bone quality and increase risk of atypical fractures of femur

Bisphosphonate treatments, proven to enhance bone density and reduce fracture incidence in post-menopausal women, may adversely affect bone quality and increase risk of atypical fractures of the femur when used for four or more years, according to preliminary research presented today at the 2010 Annual Meeting of the American Academy of Orthopaedic Surgeons.

12 Mar 2010

Manhattan Pharmaceuticals to merge with Ariston Pharmaceuticals

Manhattan Pharmaceuticals, Inc. today announced it has entered into a definitive agreement and plan of merger and completed the merger transaction with Ariston Pharmaceuticals, Inc., a privately-held, specialty pharmaceutical company. As a result of the merger, Ariston became a wholly owned subsidiary of Manhattan Pharmaceuticals.

12 Mar 2010

Independently-conducted studies confirm significant bioavailability of orally delivered insulin

ACCESS PHARMACEUTICALS, INC. announced that it has received reports of significant bioavailability of orally delivered insulin in two independently-conducted animal studies. The studies, which confirm earlier findings, were performed as part of on-going work with commercial collaborators that are evaluating Access' Cobalamin™ Oral Drug Delivery Technology.

12 Mar 2010

Age-related macular degeneration affects central vision in older Americans

Indianapolis resident Harry Traugott was an active retiree, participating in community events, driving and even teaching English as a second language at two community centers. He’d been diagnosed with age-related macular degeneration (AMD), but the disease had not caused significant vision loss. It wasn’t until he had trouble seeing while driving, watching television

11 Mar 2010

$Long-term use of bisphosphonates may adversely affect bone quality and increase risk of atypical fractures$

Long-term use of bisphosphonates may adversely affect bone quality and increase risk of atypical fractures

10 Mar 2010

Vitamin K News and Research

Latest Vitamin K News and Research

Mach One completes “Definitive Agreement” for merger and acquisition of White Hat Brands

You and your baby may need vitamin D supplementation says research

Ultraviolet portion of sunlight may play bigger role in controlling MS: Study

Understanding the African mindset may help promote health education in rural areas

H1N1 flu pandemic awareness helps Americans to be better prepared this year: Survey

Researchers find retinoic acid regulates SHF tissue formation

Low vitamin D levels in African American children connected with high asthma rates

Beneficial impact of vitamin D could alleviate symptoms and treat MS

Low-impact, weight-bearing exercise does not affect bone density during weight loss

Vitamin D supplements might do more harm than good for African-American patients

RE-LY study: Dabigatran etexilate shows greater reductions in stroke compared to warfarin

Tips for reducing LDL cholesterol

EXPLORE-Xa study: Betrixaban reduces CRNM bleeds compared to dose-adjusted warfarin

Supplementing vitamin D in people with low levels may have different effects based on patient race

ARS study underlines the importance of vitamin D and its ability to help body utilize calcium

Bisphosphonate treatments may affect bone quality and increase risk of atypical fractures of femur

Manhattan Pharmaceuticals to merge with Ariston Pharmaceuticals

Independently-conducted studies confirm significant bioavailability of orally delivered insulin

Age-related macular degeneration affects central vision in older Americans

Long-term use of bisphosphonates may adversely affect bone quality and increase risk of atypical fractures

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Vitamin K News and Research

Latest Vitamin K News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in